Filed from the Pune bureau, the report tracks developments in Business Laws for the Policy & Regulation desk. Meridian Pharma has been named in connection with the story, with early details pointing to a 5% shift relevant to the business laws landscape.
Analysts tracking the Policy & Regulation desk say the timing lines up with broader activity expected through 2027, though full details are still emerging. The Business Express will update this report as more information is confirmed.
“The numbers speak for themselves, and we expect that trend to hold through the year.”
Karthik Kapoor, Chief Strategy Officer at Meridian Pharma
Sources close to the matter say Meridian Pharma’s Pune operations are central to the development, with a figure near ₹184 crore attached to the broader plan under discussion.